CDC approves booster shots for older and immunocompromised individuals.

The CDC has recommended an additional COVID-19 booster dose for those at least 65 years old and immunocompromised individuals. The FDA has simplified the recommended COVID-19 vaccine schedule, stating that a single dose of the bivalent booster vaccine is enough for most people. The original monovalent COVID-19 vaccines from Pfizer and Moderna are no longer recommended for use in the U.S. Children between six months and 5 years old are still eligible for a multiple-dose vaccine schedule under the FDA’s guidance. The updated guidance comes as the COVID-19 public health emergency is set to end next month.